GT Biopharma Non-Current Deferred Liabilities (Quarterly) Analysis

GT Biopharma, Inc. (GTBP)

0.6575 -0.03 (-4.07%) USD | NASDAQ | Jan 14, 11:05

View Non-Current Deferred Liabilities (Quarterly) for GTBP.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Liabilities (Quarterly) Benchmarks

Start Trial

Regeneron Pharmaceuticals, Inc.	Upgrade
SELLAS Life Sciences Group, Inc.	--
Lyell Immunopharma, Inc.	--
Plus Therapeutics, Inc.	--
Geron Corp.	--